Products

The InSpectra™ StO2 Tissue Oxygenation Monitor provides continuous, real-time information for perfusion status monitoring; a new hemodynamic parameter (StO2) that assist clinicians in the early detection of inadequate tissue perfusion (hypoperfusion).  

Knowing a patient’s perfusion status – noninvasively, continuously, and in real-time – aids clinical decision-making, helps reduce and treat the incidence of shock more effectively and, ultimately, helps a facility deliver better patient care.


The InSpectra™ StO2 Tissue Oxygenation Monitor received FDA
510(k) market clearance in 2006 for the indications for use specified. In addition, the device and accessories are CE marked.
 
 




© 2010 Hutchinson Technology Incorporated all rights reserved
Home | ABOUT US | TECHNOLOGY | PRODUCTS | CLINICIAN EDUCATION | STUDIES AND TECHNICAL REFERENCES | NEWS AND EVENTS | EUROPEAN SITE | CONTACT US | SITE MAP

The InSpectra™ StO2 Tissue Oxygenation Monitor provides a noninvasive, continuous, real-time, and direct measurement of hemoglobin oxygen saturation in tissue (StO2), providing trauma teams the ability to measure tissue oxygen saturation and monitor it during resuscitation. It is the only perfusion status monitor designed for trauma environments. The InSpectra StO2 Tissue Oxygenation Monitor uses near infrared light to illuminate tissue, and then analyzes the returned light to produce a quantitative measurement of oxygen saturation in the tissue's microcirculation.

The StO2 Trauma Study researched the role that tissue oxygen saturation monitoring could play in hemorrhagic shock and resuscitation. Study results demonstrate that StO2 measurements less than 75% may indicate serious hypoperfusion in trauma patients and that StO2 functions as well as base deficit in indicating hypoperfusion in trauma patients.